FE200486
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for FE200486, covering 2009-03-20 to 2009-06-12. Get the full timeline:
Most recent: Clinical Trial Update: Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients [Phase 2]